To characterize this cohort with stage I TNBC tumors, we evaluated patient DFS, OS, and background (age, tumor size, NG, HER2/ER/PgR status, surgical procedure, and whether adjuvant radiotherapy or chemotherapy was administered). The gene discussed is ERBB2; the disease is neoplasm.